Skip to main content

WPI 3629 Pill - brown round

Pill with imprint WPI 3629 is Brown, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 8 mg. It is supplied by Watson Laboratories, Inc.

Hydromorphone is used in the treatment of Chronic Pain; Pain; Anesthetic Adjunct; Cough and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Hydromorphone 8 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3629

Hydromorphone hydrochloride extended-release 8 mg WPI 3629
Hydromorphone hydrochloride extended-release 8 mg WPI 3629

Hydromorphone Hydrochloride Extended-Release

Imprint
WPI 3629
Strength
8 mg
Color
Brown
Shape
Round
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3629 (Discontinued)
Inactive Ingredients
cellulose acetate, copovidone, hypromelloses, ferrosoferric oxide, ferric oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, propylene glycol, sodium chloride, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.